Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer CLEVELAND, OHIO, April 26, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or “Company”), an impact investing company dedicated to acquiring, reclaiming and repurposing mine...

Vitality Biopharma Welcomes New Executive Management Team – Appointment of Current Director Michael Cavanaugh as Interim Chief Executive Officer –– Promotion of Current Controller and Counsel Richard McKilligan to Chief Financial Officer – LOS ANGELES, May ...